Accelerated Pubertal Tempo in a 46,XY Aromatase-Deficient Patient
暂无分享,去创建一个
A. Belgorosky | N. Saraco | R. Marino | G. Guercio | M. Costanzo | M. Maceiras | J. Lazzati | M. Touzon | Celeste Mattone | G. Viterbo | N. Pérez Garrido | José Garcia-Feyling | Hellem Carolina Patiño
[1] N. Bishop,et al. Amalgamated Reference Data for Size‐Adjusted Bone Densitometry Measurements in 3598 Children and Young Adults—the ALPHABET Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] S. Hammes,et al. Aromatase deficiency in a male patient - Case report and review of the literature. , 2016, Bone.
[3] W. Wallace,et al. A Normative Model of Serum Inhibin B in Young Males , 2016, PloS one.
[4] B. Walker,et al. Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men , 2016, The Journal of clinical endocrinology and metabolism.
[5] A. Belgorosky,et al. Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect. , 2015, Journal of Clinical Endocrinology and Metabolism.
[6] Amit V. Pandey,et al. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies , 2014, Molecular and Cellular Endocrinology.
[7] S. Bulun. Aromatase and estrogen receptor α deficiency. , 2014, Fertility and sterility.
[8] R. Rey,et al. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. , 2011, International journal of andrology.
[9] T. Hangartner,et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. , 2010, The Journal of clinical endocrinology and metabolism.
[10] A. Belgorosky,et al. Metformin, Estrogen Replacement Therapy and Gonadotropin Inhibition Fail to Improve Insulin Sensitivity in a Girl with Aromatase Deficiency , 2009, Hormone Research in Paediatrics.
[11] A. Belgorosky,et al. Genetic and Clinical Spectrum of Aromatase Deficiency in Infancy, Childhood and Adolescence , 2009, Hormone Research in Paediatrics.
[12] V. Rochira,et al. Aromatase deficiency in men: a clinical perspective , 2009, Nature Reviews Endocrinology.
[13] E. Ghigo,et al. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. , 2008, Bone.
[14] N. Mauras,et al. Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated With Growth Hormone : A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years , 2008 .
[15] W. Crowley,et al. The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. , 2008, The Journal of clinical endocrinology and metabolism.
[16] L. Maffei,et al. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. , 2006, European journal of endocrinology.
[17] L. Dunkel,et al. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.
[18] K. Mann,et al. Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[19] S. Boonen,et al. Estrogens are essential for male pubertal periosteal bone expansion. , 2004, The Journal of clinical endocrinology and metabolism.
[20] Laura Maffei,et al. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. , 2004, The Journal of clinical endocrinology and metabolism.
[21] A. Belgorosky,et al. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. , 2003, The Journal of clinical endocrinology and metabolism.
[22] T. Saibara,et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. , 2003, The Journal of endocrinology.
[23] A. Belgorosky,et al. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys. , 2002, The Journal of clinical endocrinology and metabolism.
[24] L. Dunkel,et al. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor. , 2002, European journal of endocrinology.
[25] W. Crowley,et al. Importance of inhibin B in the regulation of FSH secretion in the human male. , 2001, The Journal of clinical endocrinology and metabolism.
[26] L. Dunkel,et al. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial , 2001, The Lancet.
[27] W. Crowley,et al. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. , 2000, The Journal of clinical endocrinology and metabolism.
[28] N. Harada,et al. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. , 1999, The Journal of clinical endocrinology and metabolism.
[29] K. Korach,et al. Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.
[30] G. Puavilai,et al. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. , 1999, Diabetes research and clinical practice.
[31] J. Bilezikian,et al. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.
[32] G. Kletter,et al. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys. , 1997, The Journal of clinical endocrinology and metabolism.
[33] K. Korach,et al. Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.
[34] E. Simpson,et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.
[35] P. A. Lee,et al. Normal ranges for immunochemiluminometric gonadotropin assays. , 1995, The Journal of pediatrics.
[36] Y. Ito,et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.
[37] W J Bremner,et al. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. , 1994, Journal of andrology.
[38] C. Mendelson,et al. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. , 1991, Molecular endocrinology.
[39] W. Crowley,et al. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. , 1991, The Journal of clinical endocrinology and metabolism.
[40] N. Harada,et al. Structural characterization of the human estrogen synthetase (aromatase) gene. , 1990, Biochemical and biophysical research communications.
[41] J. Mathis,et al. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. , 1989, The Journal of biological chemistry.